- 2013 American Transplant Congress - Novel MyD88 Inhibitor Induced Robust Tolerance in Both Cardiac and Skin Transplantation in Mice, ABackground: Toll-like receptors (TLRs) play essential role in the allograft rejection and tolerance induction. The signal transfer of TLRs, except TLR3, depends either entirely or…
- 2013 American Transplant Congress - Strong Protection Against Renal Ischemia-Reperfusion Injury by MyD88 Inhibitor in MiceObjectives: TLR signaling plays important role in renal ischemia reperfusion injury (IRI). MyD88 is the key adapter molecule in TLR pathway. This study try to…
- 2013 American Transplant Congress - Determination of Ethyl Glucuronide in Hair for Detection of Alcohol Consumption in Patients after Liver TransplantationHarmful alcohol consumption after OLT is reported in 11-26% of patients and has a negative impact on long-term outcome. Determination of alcohol marker may help…
- 2013 American Transplant Congress - Cordycepin Inhibits Lipopolysaccharide-Induced Inflammation by the Suppression of the MAPK-IκB-NF-κB Pathways in DCsBackground: Dendritic cells(DCs)are professional APC playing key roles in capturing, processing and presenting antigens as the most potent professional antigen presenting cells. Lipopolysaccharide (LPS) is…
- 2013 American Transplant Congress - Reduction in New Onset Diabetes after Renal Transplant with Erythropoietin Stimulating Agents, a Case Control StudyBackground: New-onset diabetes mellitus after transplantation (NODAT) adversely affects graft and patient survival. Approximately 10-15 % of post-renal transplant patients require an erythropoietin stimulating agent…
- 2013 American Transplant Congress - Effect of C1-Esterase Inhibitor (Human) on a Murine Acute Liver Failure Model, The- Univeristy of Massachusetts, Worcester Acute liver failure (ALF) is associated with a high mortality rate. The incidence of ALF is approximately 2000 cases annually. Drug-related hepatotoxicity accounts for more…
- 2013 American Transplant Congress - Effect of C1-Esterase Inhibitor (Human) on Liver Ischemia-Reperfusion Injury and Regeneration, The- University of Massachusetts Medical School, Worcester Liver ischemia-reperfusion injury (IRI) is a well-known cause of morbidity and mortality following liver transplantation (LT). Activation of the complement system, especially the lectin pathway,…
- 2013 American Transplant Congress - PROTECT Study: 35 Months of Everolimus Monotherapy vs. Calcineurin Inhibitor-Based Therapy Showed To Be a Safe Alternative with Superior Renal Function in Liver Transplant Recipients, ThePost-transplant immunosuppression with calcineurin inhibitors (CNIs) is associated with impaired renal function. The PROTECT study showed that conversion from CNI to the mTOR-inhibitor everolimus (EVR)…
- 2013 American Transplant Congress - Aggravation of Post-Ischemic Liver Injury by Overexpression of IGFBP-3Insulin-like growth factor binding protein-3 (IGFBP-3) is known to interfere NF-ΚB signaling pathway in response to a diverse range of stimuli. Liver ischemia/reperfusion injury is…
- 2013 American Transplant Congress - TNF-alpha -238 G-Allele Predisposes to Severe Bacterial Infection in Patients with End-Stage Liver Disease Enlisted for Liver Transplantation, TheBackground: Augmented susceptibility to infections increases mortality in patients with end-stage liver disease (ESLD). Activation of pro-inflammatory cytokine production via TLR4, which is a major…
- « Previous Page
- 1
- …
- 46
- 47
- 48
- 49
- 50
- …
- 178
- Next Page »
